RBF Capital’s Alimera Sciences ALIM Stock Holding History
Bought
Maintained
Sold
RBF Capital's ALIM Position: Q3 2024 in Review
RBF Capital sold out of Alimera Sciences (ALIM) in Q3 2024, closing a stake of 60,000 shares — an estimated $334K sold.
RBF Capital first reported a position in ALIM in Q2 2024 and held it in 1 quarter. The position peaked at $334K in Q2 2024. 0 funds tracked by Wall St. Rank hold ALIM as of Q3 2024.
- RBF Capital reported no remaining Alimera Sciences position as of Q3 2024 after selling out during the quarter.
- RBF Capital sold 60,000 Alimera Sciences shares in Q3 2024, an estimated $334K.
- RBF Capital first reported a position in Alimera Sciences in Q2 2024 and held it in 1 quarter.
- RBF Capital's Alimera Sciences position peaked at $334K in Q2 2024.
- 0 funds tracked by Wall St. Rank held Alimera Sciences as of Q3 2024.
Based on RBF Capital's 13F filing for Q3 2024, filed 14 Nov 2024.